[1]
Wu, C. and Yang, J. 2026. Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. World Journal of Oncology. 17, 3 (Jan. 2026), 347–356. DOI:https://doi.org/10.14740/wjon2727.